CM Life Sciences, Inc. Profile Avatar - Palmy Investing

CM Life Sciences, Inc.

CM Life Sciences, Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.

Shell Companies
US, New York [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

CM Life Sciences, Inc. has no acquisition track records yet.

M&A Deals · History

CM Life Sciences, Inc. has no acquisition track records yet.

M&A Deals · Within Industry

No current deals within Shell Companies Industry.

M&A Deals · Latest

Act, dont react; Track the most urgent M&A deals across all industries

Details
Owens Corning
Debt
Agg. Maximum Price
$373,155,000.00
Details
?
Equity
Agg. Maximum Price
$n/a
Details
?
Equity
Agg. Maximum Price
$4,221.65
?
Details
?
Equity
Agg. Maximum Price
$2,264,484.00
Details
United Bankshares, Inc.
Equity
Agg. Maximum Price
$206,633,909.86
?
Details
?
Equity
Agg. Maximum Price
$381.73
Details
?
Equity
Agg. Maximum Price
$7,657,428.54
Details
Icahn Enterprises L.P.
Debt
Agg. Maximum Price
$700,000,000.00
?
Details
?
Equity
Agg. Maximum Price
$19,377,844.50
Details
Corebridge Financial, Inc.
Debt
Agg. Maximum Price
$500,000,000.00
End of CMLFU's Analysis
CIK: 1818331 CUSIP: - ISIN: US18978W2089 LEI: - UEI: -
Secondary Listings
CMLFU has no secondary listings inside our databases.